NCT07274358Completed
HopeMove App in Pediatric Cancer Patients
HopeMove: Feasibility and Acceptability of a Mobile Application to Promote Physical Activity in Pediatric Hemotology and Oncology Patients
Source: ClinicalTrials.gov · Last updated 10 Dec 2025
Brief summary (registry, in English)
This pilot feasibility study aims to assess the acceptability, usability, safety, and initial effects of the HopeMove mobile health app on fatigue in adolescents aged 13 to 18 years undergoing hematology-oncology treatment. HopeMove is a wearable-compatible app that offers guided home exercise sessions and daily symptom tracking to support physical activity and monitor well-being during treatment. The study includes an expert usability evaluation with 10 clinicians, a one-week usability testing phase with 15 adolescents, and an eight-week intervention period in which participants complete at least three exercise sessions per week using the app. Outcomes include usability measured with the Mobile Application Usability Scale, satisfaction assessed via a Visual Analog Scale, and fatigue evaluated with the Fatigue Scale. The findings are expected to provide evidence on the feasibility, usability, and potential clinical benefits of mobile-supported exercise programs for children and adolescents undergoing cancer treatment.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 15 (actual)
- First submitted
- 27 Nov 2025
- Start date
- 1 Aug 2025
- Primary completion date
- 15 Nov 2025
- Lead sponsor
- Koç University
- Diseases
- Childhood cancers
- NCT number
- NCT07274358
What you commit to
- Study type: Interventional
- Participants enrolled: 15
- From 1 Aug 2025 to the primary completion date, 15 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- having received analgesics within the past 2 hours,
- using antiepileptic medication,
Other illness
- having a chronic illness requiring regular invasive procedures,
- having experienced a seizure within the past 2 hours,
Other
- having a body temperature above 37.5°C
- not having parental consent,
- being agitated at the time of the procedure,
- having any auditory or visual impairments.
Who the study is looking for
- adolescents aged 13-18 years
- receiving active hematology-oncology treatment
- able to use a smartphone running Android operating system
- has internet access
- voluntarily agrees to participate
- parent/guardian consent obtained (if applicable)
- able to perform light-moderate exercise
- able to complete at least 75% of planned exercise sessions
Age in the registry: 13 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul University Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.